D03.122 - Melanoma in situ of left lower eyelid, including canthus

Version 2023

ICD-10:	D03.122
Short Description:	Melanoma in situ of left lower eyelid, including canthus
Long Description:	Melanoma in situ of left lower eyelid, including canthus
Status:	Valid for Submission
Version:	ICD-10-CM 2023
Code Classification:	Neoplasms (C00–D48) In situ neoplasms (D00-D09) Melanoma in situ (D03)

1. Tabular List of Diseases and Injuries
2. Diagnostic Related Groups - MS-DRG Mapping
3. Replacement Code
4. Patient Education
5. Related Codes Browser
6. Code History

D03.122 is a billable ICD-10 code used to specify a medical diagnosis of melanoma in situ of left lower eyelid, including canthus. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

Diagnostic Related Groups - MS-DRG Mapping

The is diagnosis code is grouped in the following groups for version MS-DRG V40.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2022 through 09/30/2023.

MS-DRG	MS-DRG Title	MCD	Relative Weight
124	OTHER DISORDERS OF THE EYE WITH MCC	02	1.4007
125	OTHER DISORDERS OF THE EYE WITHOUT MCC	02	0.8621

The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Replacement Code

D03122 replaces the following previously assigned ICD-10 code(s):

D03.12 - Melanoma in situ of left eyelid, including canthus

Patient Education

Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

Asymmetry - the shape of one half does not match the other
Border - the edges are ragged, blurred or irregular
Color - the color is uneven and may include shades of black, brown and tan
Diameter - there is a change in size, usually an increase
Evolving - the mole has changed over the past few weeks or months

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute

[Learn More in MedlinePlus]

Melanoma Summary

Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Skin Cancer (Including Melanoma)-Patient Version

Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Related Codes Browser

ICD Code	Description	Valid for Submission
D03	Melanoma in situ	NON-BILLABLE CODE
D03.0	Melanoma in situ of lip	BILLABLE CODE
D03.1	Melanoma in situ of eyelid, including canthus	NON-BILLABLE CODE
D03.10	Melanoma in situ of unspecified eyelid, including canthus	BILLABLE CODE
D03.11	Melanoma in situ of right eyelid, including canthus	NON-BILLABLE CODE
D03.111	Melanoma in situ of right upper eyelid, including canthus	BILLABLE CODE
D03.112	Melanoma in situ of right lower eyelid, including canthus	BILLABLE CODE
D03.12	Melanoma in situ of left eyelid, including canthus	NON-BILLABLE CODE
D03.121	Melanoma in situ of left upper eyelid, including canthus	BILLABLE CODE
D03.2	Melanoma in situ of ear and external auricular canal	NON-BILLABLE CODE
D03.20	Melanoma in situ of unspecified ear and external auricular canal	BILLABLE CODE
D03.21	Melanoma in situ of right ear and external auricular canal	BILLABLE CODE
D03.22	Melanoma in situ of left ear and external auricular canal	BILLABLE CODE
D03.3	Melanoma in situ of other and unspecified parts of face	NON-BILLABLE CODE
D03.30	Melanoma in situ of unspecified part of face	BILLABLE CODE
D03.39	Melanoma in situ of other parts of face	BILLABLE CODE
D03.4	Melanoma in situ of scalp and neck	BILLABLE CODE
D03.5	Melanoma in situ of trunk	NON-BILLABLE CODE
D03.51	Melanoma in situ of anal skin	BILLABLE CODE
D03.52	Melanoma in situ of breast (skin) (soft tissue)	BILLABLE CODE
D03.59	Melanoma in situ of other part of trunk	BILLABLE CODE
D03.6	Melanoma in situ of upper limb, including shoulder	NON-BILLABLE CODE
D03.60	Melanoma in situ of unspecified upper limb, including shoulder	BILLABLE CODE
D03.61	Melanoma in situ of right upper limb, including shoulder	BILLABLE CODE
D03.62	Melanoma in situ of left upper limb, including shoulder	BILLABLE CODE
D03.7	Melanoma in situ of lower limb, including hip	NON-BILLABLE CODE
D03.70	Melanoma in situ of unspecified lower limb, including hip	BILLABLE CODE
D03.71	Melanoma in situ of right lower limb, including hip	BILLABLE CODE
D03.72	Melanoma in situ of left lower limb, including hip	BILLABLE CODE
D03.8	Melanoma in situ of other sites	BILLABLE CODE
D03.9	Melanoma in situ, unspecified	BILLABLE CODE

Code History

FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019

Previous Code: D03.121

Parent Code: D03.12

Next Code: D03.2

Table of Contents